ACHILLION PHARMACEUTICALS INC Forms 3, 4 and 5: Preferred Stock
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 87 rows, 87 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2006-10-31: Reporting owner FISHERMAN JASON S; Form 4/A; Security Series B Convertible Preferred Stock; Transaction C Conversion of derivative security.
- 2006-10-31: Reporting owner FISHERMAN JASON S; Form 4/A; Security Series C Convertible Preferred Stock; Transaction C Conversion of derivative security.
- 2006-10-31: Reporting owner FISHERMAN JASON S; Form 4/A; Security Series C-2 Convertible Preferred Stock; Transaction C Conversion of derivative security.
- 2006-10-31: Reporting owner FISHERMAN JASON S; Form 4; Security Series B Convertible Preferred Stock; Transaction C Conversion of derivative security.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2006-10-31 | FISHERMAN JASON S Director | 4/A | Series B Convertible Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −4,820 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-31 | FISHERMAN JASON S Director | 4/A | Series C Convertible Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −1,653 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-31 | FISHERMAN JASON S Director | 4/A | Series C-2 Convertible Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −2,133 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-31 | FISHERMAN JASON S Director | 4 | Series B Convertible Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −4,820 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-31 | FISHERMAN JASON S Director | 4 | Series C Convertible Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −1,653 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-31 | FISHERMAN JASON S Director | 4 | Series C-2 Convertible Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −2,133 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-31 | ADVENT PARTNERS LIMITED PARTNERSHIP Other (Member of group no longer >10%) | 4 | Series B Convertible Preferred Stock Derivative · Direct | C Conversion of derivative security | −39,530 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-31 | ADVENT PARTNERS LIMITED PARTNERSHIP Other (Member of group no longer >10%) | 4 | Series C Convertible Preferred Stock Derivative · Direct | C Conversion of derivative security | −13,558 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-31 | ADVENT PARTNERS LIMITED PARTNERSHIP Other (Member of group no longer >10%) | 4 | Series C-2 Convertible Preferred Stock Derivative · Direct | C Conversion of derivative security | −17,496 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-31 | ADVENT PARTNERS HLS II LIMITED PARTNERSHIP Other (Member of group no longer >10%) | 4 | Series B Convertible Preferred Stock Derivative · Direct | C Conversion of derivative security | −96,412 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-31 | ADVENT PARTNERS HLS II LIMITED PARTNERSHIP Other (Member of group no longer >10%) | 4 | Series C Convertible Preferred Stock Derivative · Direct | C Conversion of derivative security | −33,069 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-31 | ADVENT PARTNERS HLS II LIMITED PARTNERSHIP Other (Member of group no longer >10%) | 4 | Series C-2 Convertible Preferred Stock Derivative · Direct | C Conversion of derivative security | −42,675 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-31 | ADVENT INTERNATIONAL LIMITED PARTNERSHIP Other (Member of group no longer >10%) | 4 | Series B Convertible Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −4,684,695 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-31 | ADVENT INTERNATIONAL LIMITED PARTNERSHIP Other (Member of group no longer >10%) | 4 | Series C Convertible Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −1,606,805 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-31 | ADVENT INTERNATIONAL LIMITED PARTNERSHIP Other (Member of group no longer >10%) | 4 | Series C-2 Convertible Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −2,073,582 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-31 | ADVENT INTERNATIONAL CORP/MA Other (Member of group no longer >10%) | 4 | Series B Convertible Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −4,820,637 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-31 | ADVENT INTERNATIONAL CORP/MA Other (Member of group no longer >10%) | 4 | Series C Convertible Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −1,653,432 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-31 | ADVENT INTERNATIONAL CORP/MA Other (Member of group no longer >10%) | 4 | Series C-2 Convertible Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −2,133,753 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-31 | ADVENT HEALTHCARE & LIFE SCIENCES II LP Other (Member of group no longer >10%) | 4 | Series B Convertible Preferred Stock Derivative · Direct | C Conversion of derivative security | −4,346,286 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-31 | ADVENT HEALTHCARE & LIFE SCIENCES II LP Other (Member of group no longer >10%) | 4 | Series C Convertible Preferred Stock Derivative · Direct | C Conversion of derivative security | −1,490,734 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-31 | ADVENT HEALTHCARE & LIFE SCIENCES II LP Other (Member of group no longer >10%) | 4 | Series C-2 Convertible Preferred Stock Derivative · Direct | C Conversion of derivative security | −1,923,793 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-31 | ADVENT HEALTHCARE & LIFE SCIENCES II KG Other (Member of group no longer >10%) | 4 | Series B Convertible Preferred Stock Derivative · Direct | C Conversion of derivative security | −338,409 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-31 | ADVENT HEALTHCARE & LIFE SCIENCES II KG Other (Member of group no longer >10%) | 4 | Series C Convertible Preferred Stock Derivative · Direct | C Conversion of derivative security | −116,071 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-31 | ADVENT HEALTHCARE & LIFE SCIENCES II KG Other (Member of group no longer >10%) | 4 | Series C-2 Convertible Preferred Stock Derivative · Direct | C Conversion of derivative security | −149,789 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-31 | SCHRODER VENTURES MANAGERS INC | SCHRODER VENTURES INTERNATIONAL LIFE SCIENCES FUND II LP1 | Schroder Ventures International Life Sciences Fund II L.P.2 | SV (Nominees) LTD as Nominee of Schroder Ventures Investments LTD | SCHRODER VENTURE MANAGERS LTD | SITCO Nominees Ltd. VC 01903 as Nominee of Schroder Ventures International Life Sciences Fund II Group Co-Investment Scheme | Schroder Ventures International Life Sciences Fund II Strategic Partners L.P. | Schroder Ventures International Life Sciences Fund II L.P.3 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series B Convertible Preferred Stock Derivative · Indirect · See Footonte | C Conversion of derivative security | −6,071,204 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-31 | SCHRODER VENTURES MANAGERS INC | SCHRODER VENTURES INTERNATIONAL LIFE SCIENCES FUND II LP1 | Schroder Ventures International Life Sciences Fund II L.P.2 | SV (Nominees) LTD as Nominee of Schroder Ventures Investments LTD | SCHRODER VENTURE MANAGERS LTD | SITCO Nominees Ltd. VC 01903 as Nominee of Schroder Ventures International Life Sciences Fund II Group Co-Investment Scheme | Schroder Ventures International Life Sciences Fund II Strategic Partners L.P. | Schroder Ventures International Life Sciences Fund II L.P.3 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series C Convertible Preferred Stock Derivative · Indirect · See Footonte | C Conversion of derivative security | −3,306,866 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-31 | SCHRODER VENTURES MANAGERS INC | SCHRODER VENTURES INTERNATIONAL LIFE SCIENCES FUND II LP1 | Schroder Ventures International Life Sciences Fund II L.P.2 | SV (Nominees) LTD as Nominee of Schroder Ventures Investments LTD | SCHRODER VENTURE MANAGERS LTD | SITCO Nominees Ltd. VC 01903 as Nominee of Schroder Ventures International Life Sciences Fund II Group Co-Investment Scheme | Schroder Ventures International Life Sciences Fund II Strategic Partners L.P. | Schroder Ventures International Life Sciences Fund II L.P.3 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series C-2 Convertible Preferred Stock Derivative · Indirect · See Footonte | C Conversion of derivative security | −3,656,461 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-31 | GARVEY JAMES M Director, 10% Owner | 4 | Series B Convertible Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −6,071,204 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-31 | GARVEY JAMES M Director, 10% Owner | 4 | Series C Convertible Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −3,306,866 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-31 | GARVEY JAMES M Director, 10% Owner | 4 | Series C-2 Convertible Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −3,656,461 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-31 | FORMELA JEAN FRANCOIS Director, 10% Owner | 4 | Series B Convertible Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −6,071,207 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-31 | FORMELA JEAN FRANCOIS Director, 10% Owner | 4 | Series C Convertible Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −4,629,610 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-31 | FORMELA JEAN FRANCOIS Director, 10% Owner | 4 | Series C-2 Convertible Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −4,142,227 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-31 | ATLAS VENTURE ENTREPRENEURS FUND V LP | ATLAS VENTURE ASSOCIATES V LP | ATLAS VENTURE FUND V LP | ATLAS VENTURE PARALLEL FUND V-A C V 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series B Convertible Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −6,071,207 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-31 | ATLAS VENTURE ENTREPRENEURS FUND V LP | ATLAS VENTURE ASSOCIATES V LP | ATLAS VENTURE FUND V LP | ATLAS VENTURE PARALLEL FUND V-A C V 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series C Convertible Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −4,629,610 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-31 | ATLAS VENTURE ENTREPRENEURS FUND V LP | ATLAS VENTURE ASSOCIATES V LP | ATLAS VENTURE FUND V LP | ATLAS VENTURE PARALLEL FUND V-A C V 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series C-2 Convertible Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −4,142,227 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-31 | WHITE CHRISTOPHER A Director | 4 | Series C Convertible Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −5,125,639 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-31 | WHITE CHRISTOPHER A Director | 4 | Series C-2 Convertible Preferred Stock Derivative · Direct · (m) | C Conversion of derivative security | −17,941 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-31 | WHITE CHRISTOPHER A Director | 4 | Series C-2 Convertible Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −1,250,476 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-31 | Scheer David Director | 4 | Series B Convertible Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −19,647 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-31 | Scheer David Director | 4 | Series C-2 Convertible Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −3,880 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-31 | RYSER STEFAN Director | 4 | Series C Convertible Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −4,960,296 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-31 | RYSER STEFAN Director | 4 | Series C-2 Convertible Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −1,907,844 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-31 | GILEAD SCIENCES INC 10% Owner | 4 | Series C-1 Convertible Preferred Stock Derivative · Direct | C Conversion of derivative security | −2,478,721 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-31 | GILEAD SCIENCES INC 10% Owner | 4 | Series C-2 Convertible Preferred Stock Derivative · Direct | C Conversion of derivative security | −5,962,766 0 owned after | $0.00 | 2006-11-02 | |
| 2006-10-25 holding as of filing | Schroder Ventures International Life Sciences Fund II L.P.3 | SCHRODER VENTURES MANAGERS INC | SCHRODER VENTURE MANAGERS LTD | Schroder Ventures International Life Sciences Fund II L.P.2 | SITCO Nominees Ltd. VC 01903 as Nominee of Schroder Ventures International Life Sciences Fund II Group Co-Investment Scheme | Schroder Ventures International Life Sciences Fund II Strategic Partners L.P. | SV (Nominees) LTD as Nominee of Schroder Ventures Investments LTD | SCHRODER VENTURES INTERNATIONAL LIFE SCIENCES FUND II LP1 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series B Convertible Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2006-10-25 | ||
| 2006-10-25 holding as of filing | Schroder Ventures International Life Sciences Fund II L.P.3 | SCHRODER VENTURES MANAGERS INC | SCHRODER VENTURE MANAGERS LTD | Schroder Ventures International Life Sciences Fund II L.P.2 | SITCO Nominees Ltd. VC 01903 as Nominee of Schroder Ventures International Life Sciences Fund II Group Co-Investment Scheme | Schroder Ventures International Life Sciences Fund II Strategic Partners L.P. | SV (Nominees) LTD as Nominee of Schroder Ventures Investments LTD | SCHRODER VENTURES INTERNATIONAL LIFE SCIENCES FUND II LP1 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series C Convertible Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2006-10-25 | ||
| 2006-10-25 holding as of filing | Schroder Ventures International Life Sciences Fund II L.P.3 | SCHRODER VENTURES MANAGERS INC | SCHRODER VENTURE MANAGERS LTD | Schroder Ventures International Life Sciences Fund II L.P.2 | SITCO Nominees Ltd. VC 01903 as Nominee of Schroder Ventures International Life Sciences Fund II Group Co-Investment Scheme | Schroder Ventures International Life Sciences Fund II Strategic Partners L.P. | SV (Nominees) LTD as Nominee of Schroder Ventures Investments LTD | SCHRODER VENTURES INTERNATIONAL LIFE SCIENCES FUND II LP1 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series C-2 Convertible Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2006-10-25 | ||
| 2006-10-25 holding as of filing | ATLAS VENTURE PARALLEL FUND V-A C V | ATLAS VENTURE FUND V LP | ATLAS VENTURE ASSOCIATES V LP | ATLAS VENTURE ENTREPRENEURS FUND V LP 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series B Convertible Preferred Stock Derivative · Indirect · See footnote | Holding | no price filed | 2006-10-25 | ||
| 2006-10-25 holding as of filing | ATLAS VENTURE PARALLEL FUND V-A C V | ATLAS VENTURE FUND V LP | ATLAS VENTURE ASSOCIATES V LP | ATLAS VENTURE ENTREPRENEURS FUND V LP 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series C Convertible Preferred Stock Derivative · Indirect · See footnote | Holding | no price filed | 2006-10-25 | ||
| 2006-10-25 holding as of filing | ATLAS VENTURE PARALLEL FUND V-A C V | ATLAS VENTURE FUND V LP | ATLAS VENTURE ASSOCIATES V LP | ATLAS VENTURE ENTREPRENEURS FUND V LP 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series C-2 Convertible Preferred Stock Derivative · Indirect · See footnote | Holding | no price filed | 2006-10-25 | ||
| 2006-10-25 holding as of filing | FORMELA JEAN FRANCOIS Director, 10% Owner | 3 | Series B Convertible Preferred Stock Derivative · Indirect · See footnote | Holding | no price filed | 2006-10-25 | ||
| 2006-10-25 holding as of filing | FORMELA JEAN FRANCOIS Director, 10% Owner | 3 | Series C Convertible Preferred Stock Derivative · Indirect · See footnote | Holding | no price filed | 2006-10-25 | ||
| 2006-10-25 holding as of filing | FORMELA JEAN FRANCOIS Director, 10% Owner | 3 | Series C-2 Convertible Preferred Stock Derivative · Indirect · See footnote | Holding | no price filed | 2006-10-25 | ||
| 2006-10-25 holding as of filing | WHITE CHRISTOPHER A Director | 3 | Series C Convertible Preferred Stock Derivative · Indirect · (m) | Holding | no price filed | 2006-10-25 | ||
| 2006-10-25 holding as of filing | WHITE CHRISTOPHER A Director | 3 | Series C-2 Convertible Preferred Stock Derivative · Direct · (m) | Holding | no price filed | 2006-10-25 | ||
| 2006-10-25 holding as of filing | WHITE CHRISTOPHER A Director | 3 | Series C-2 Convertible Preferred Stock Derivative · Indirect · (m) | Holding | no price filed | 2006-10-25 | ||
| 2006-10-25 holding as of filing | GARVEY JAMES M Director, 10% Owner | 3 | Series B Convertible Preferred Stock Derivative · Indirect · See footnote | Holding | no price filed | 2006-10-25 | ||
| 2006-10-25 holding as of filing | GARVEY JAMES M Director, 10% Owner | 3 | Series C Convertible Preferred Stock Derivative · Indirect · See footnote | Holding | no price filed | 2006-10-25 | ||
| 2006-10-25 holding as of filing | GARVEY JAMES M Director, 10% Owner | 3 | Series C-2 Convertible Preferred Stock Derivative · Indirect · See footnote | Holding | no price filed | 2006-10-25 | ||
| 2006-10-25 holding as of filing | RYSER STEFAN Director | 3 | Series C Convertible Preferred Stock Derivative · Indirect · See footnote | Holding | no price filed | 2006-10-25 | ||
| 2006-10-25 holding as of filing | RYSER STEFAN Director | 3 | Series C-2 Convertible Preferred Stock Derivative · Indirect · See footnote | Holding | no price filed | 2006-10-25 | ||
| 2006-10-25 holding as of filing | Scheer David Director | 3 | Series B Convertible Preferred Stock Derivative · Indirect · See footnote | Holding | no price filed | 2006-10-25 | ||
| 2006-10-25 holding as of filing | Scheer David Director | 3 | Series C-2 Convertible Preferred Stock Derivative · Indirect · See footnote | Holding | no price filed | 2006-10-25 | ||
| 2006-10-25 holding as of filing | GILEAD SCIENCES INC 10% Owner | 3 | Series C-1 Convertible Preferred Stock Derivative · Direct | Holding | no price filed | 2006-10-25 | ||
| 2006-10-25 holding as of filing | GILEAD SCIENCES INC 10% Owner | 3 | Series C-2 Convertible Preferred Stock Derivative · Direct | Holding | no price filed | 2006-10-25 | ||
| 2006-10-25 holding as of filing | FISHERMAN JASON S Director | 3 | Series B Convertible Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2006-10-25 | ||
| 2006-10-25 holding as of filing | FISHERMAN JASON S Director | 3 | Series C Convertible Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2006-10-25 | ||
| 2006-10-25 holding as of filing | FISHERMAN JASON S Director | 3 | Series C-2 Convertible Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2006-10-25 | ||
| 2006-10-25 holding as of filing | ADVENT HEALTHCARE & LIFE SCIENCES II KG Other (Member of group > 10%) | 3 | Series B Convertible Preferred Stock Derivative · Direct | Holding | no price filed | 2006-10-25 | ||
| 2006-10-25 holding as of filing | ADVENT HEALTHCARE & LIFE SCIENCES II KG Other (Member of group > 10%) | 3 | Series C Convertible Preferred Stock Derivative · Direct | Holding | no price filed | 2006-10-25 | ||
| 2006-10-25 holding as of filing | ADVENT HEALTHCARE & LIFE SCIENCES II KG Other (Member of group > 10%) | 3 | Series C-2 Convertible Preferred Stock Derivative · Direct | Holding | no price filed | 2006-10-25 | ||
| 2006-10-25 holding as of filing | ADVENT HEALTHCARE & LIFE SCIENCES II LP Other (Member of group > 10%) | 3 | Series B Convertible Preferred Stock Derivative · Direct | Holding | no price filed | 2006-10-25 | ||
| 2006-10-25 holding as of filing | ADVENT HEALTHCARE & LIFE SCIENCES II LP Other (Member of group > 10%) | 3 | Series C Convertible Preferred Stock Derivative · Direct | Holding | no price filed | 2006-10-25 | ||
| 2006-10-25 holding as of filing | ADVENT HEALTHCARE & LIFE SCIENCES II LP Other (Member of group > 10%) | 3 | Series C-2 Convertible Preferred Stock Derivative · Direct | Holding | no price filed | 2006-10-25 | ||
| 2006-10-25 holding as of filing | ADVENT PARTNERS HLS II LIMITED PARTNERSHIP Other (Member of group > 10%) | 3 | Series B Convertible Preferred Stock Derivative · Direct | Holding | no price filed | 2006-10-25 | ||
| 2006-10-25 holding as of filing | ADVENT PARTNERS HLS II LIMITED PARTNERSHIP Other (Member of group > 10%) | 3 | Series C Convertible Preferred Stock Derivative · Direct | Holding | no price filed | 2006-10-25 | ||
| 2006-10-25 holding as of filing | ADVENT PARTNERS HLS II LIMITED PARTNERSHIP Other (Member of group > 10%) | 3 | Series C-2 Convertible Preferred Stock Derivative · Direct | Holding | no price filed | 2006-10-25 | ||
| 2006-10-25 holding as of filing | ADVENT PARTNERS LIMITED PARTNERSHIP Other (Member of group > 10%) | 3 | Series B Convertible Preferred Stock Derivative · Direct | Holding | no price filed | 2006-10-25 | ||
| 2006-10-25 holding as of filing | ADVENT PARTNERS LIMITED PARTNERSHIP Other (Member of group > 10%) | 3 | Series C Convertible Preferred Stock Derivative · Direct | Holding | no price filed | 2006-10-25 | ||
| 2006-10-25 holding as of filing | ADVENT PARTNERS LIMITED PARTNERSHIP Other (Member of group > 10%) | 3 | Series C-2 Convertible Preferred Stock Derivative · Direct | Holding | no price filed | 2006-10-25 | ||
| 2006-10-25 holding as of filing | ADVENT INTERNATIONAL LIMITED PARTNERSHIP Other (Member of group > 10%) | 3 | Series B Convertible Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2006-10-25 | ||
| 2006-10-25 holding as of filing | ADVENT INTERNATIONAL LIMITED PARTNERSHIP Other (Member of group > 10%) | 3 | Series C Convertible Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2006-10-25 | ||
| 2006-10-25 holding as of filing | ADVENT INTERNATIONAL LIMITED PARTNERSHIP Other (Member of group > 10%) | 3 | Series C-2 Convertible Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2006-10-25 | ||
| 2006-10-25 holding as of filing | ADVENT INTERNATIONAL CORP/MA Other (Member of group > 10%) | 3 | Series B Convertible Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2006-10-25 | ||
| 2006-10-25 holding as of filing | ADVENT INTERNATIONAL CORP/MA Other (Member of group > 10%) | 3 | Series C Convertible Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2006-10-25 | ||
| 2006-10-25 holding as of filing | ADVENT INTERNATIONAL CORP/MA Other (Member of group > 10%) | 3 | Series C-2 Convertible Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2006-10-25 |